Latest Medicare Solvency Projections Highlight the Need for Reforms to Improve Medicare’s Fiscal Outlook
Medicare Sustainability
Latest Medicare Solvency Projections Highlight the Need for Reforms to Improve Medicare’s Fiscal Outlook
What’s Going on with Medicare Advantage? Arnold Ventures Experts Explain.
Medicare Sustainability
What’s Going on with Medicare Advantage? Arnold Ventures Experts Explain.
Our Take on the 2023 State of the Union
Policing
Our Take on the 2023 State of the Union
5 Things to Watch in 2023 in Health Care
Drug Prices
5 Things to Watch in 2023 in Health Care
Look Ahead
5 Big Wins in 2022 for Health Care
Drug Prices
5 Big Wins in 2022 for Health Care
2022 Year in Review
22 Stories of Change from 2022
Policing
22 Stories of Change from 2022
2022 Year in Review
3 Questions with a MacArthur 'Genius'
Drug Prices
3 Questions with a MacArthur ‘Genius’
Q&A
How Medicare Drug Price Negotiations Finally Became Law
Drug Prices
How Medicare Drug Price Negotiations Finally Became Law
Q&A
Medicare Advantage’s Exponential Growth Spurs Scrutiny
Medicare-Medicaid Integration
Medicare Advantage’s Exponential Growth Spurs Scrutiny
3 Ways Drug Pricing Reforms in Congress Will Help People
Drug Prices
3 Ways Drug Pricing Reforms in Congress Will Help People
Four Takeaways from a Congressional Hearing on Oversight of Medicare Advantage Plans
Medicare Sustainability
Four Takeaways from a Congressional Hearing on Oversight of Medicare Advantage Plans
Medicare Sustainability
Medicare Solvency Projections Underscore Need for Reform
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Drug Prices
High Brand-Name Net Prices — and List Prices — Support Reforms to Medicare Part D
Medicare Negotiation Hearing: 3 Key Takeaways
Drug Prices
Medicare Negotiation Hearing: 3 Key Takeaways
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
Medicare-Medicaid Integration
AV Calls for Changes to Medicare Advantage to Reduce Overpayments
A New Generation in the Fight for Fair Drug Prices
Drug Prices
A New Generation in the Fight for Fair Drug Prices
Q&A
A New Way to Begin the End of HIV in the U.S.
Drug Prices
A New Way to Begin the End of HIV in the U.S.
Q&A
Congress: Pharma's Price Gouging is Purposeful
Drug Prices
Congress: Pharma’s Price Gouging is Purposeful
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Prices
Maximizing Opportunity, Minimizing Injustice for Our Nation’s Veterans
Drug Pricing Reform Failure is Unacceptable
Drug Prices
Drug Pricing Reform Failure is Unacceptable
Op-Ed
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Prices
Part 3: After a Groundswell of Success in 2021, Stage is Set for Broader Rx Reform in 2022
Drug Affordability
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Prices
Part 2: In Quest to Lower Rx Prices, States Deploy New Tools
Drug Affordability
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Prices
Part 1: As Congress Debates Lowering Drug Prices, States Waste No Time
Drug Affordability
5 Things to Watch for in the Medicare Trustees’ Report
Medicare Sustainability
5 Things to Watch for in the Medicare Trustees’ Report
About Us
We strive to maximize opportunity and minimize injustice by investing in systemic solutions that will outlast our funding.
